UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043358
Receipt number R000049483
Scientific Title Exploratory Report: "Initial Report: A Unique Three-Dimensional Elastic Liver Model with Emulator Functionality; Evaluation to the theme that the Simulation Model Assisting Resection Technique of Liver (SMART Liver) has an emulation function"
Date of disclosure of the study information 2021/02/23
Last modified on 2021/02/19 11:21:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation to the theme that the Simulation Model Assisting Resection Technique of Liver (SMART Liver) has an emulation function

Acronym

E-SMART Liver

Scientific Title

Exploratory Report: "Initial Report: A Unique Three-Dimensional Elastic Liver Model with Emulator Functionality; Evaluation to the theme that the Simulation Model Assisting Resection Technique of Liver (SMART Liver) has an emulation function"

Scientific Title:Acronym

Exploratory Report: E-SMART Liver

Region

Japan


Condition

Condition

hepatic disease

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

In hepatic treatment, high-level skills and experience are indispensable. Preoperative simulations have become a valid approach and are widely used. However, at present, it is complicated to perform physical simulations on simulated images with real-time liver deformity requires a lot of calculations and to simultaneously reproduce the nonrigid registration of the liver with elasticity on the monitor during surgery. Therefore, this study aimed to develop a patient-specific 3D liver model (Simulation Model Assisting Resection Technique of Liver, or SMART Liver) to reproduce in vivo conditions and to enable preoperative simulations, including nonrigid registration.
The 3DLM's validity were investigated by questionnaire survey to doctors engaged in liver treatment.
After the initial physical simulation with SMART Liver, the learning curve of sequential laparoscopic lateral sectionectomy operations performed by one operator was investigated retrospectively.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Theme that the 3D model has an emulation function in teaching residents were investigated on a 5-point scale (5: excellent; 4: good; 3: fair; 2: poor; 1: unacceptable) after watching an instructional video
1) reproducibility
the images obtained from the 3D model properly depict information
transparency
tolerability of imaging devices (ultrasonography)
tolerability of imaging devices (CT)
appropriate for training the therapeutic techniques (real-time virtual sonography, puncture technique, interventional approach)
appropriate for training the therapeutic techniques (puncture technique)
appropriate for training the therapeutic techniques (interventional approach)
appropriate for training the therapeutic techniques (laparoscopic lateral sectionectomy)

Key secondary outcomes

Number of cases to reach the appropriate operative time on the learning curve.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment

Interventions/Control_1

Instructing doctors

Interventions/Control_2

Practitioner

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Questionnaire survey target doctors
Doctors involved in liver treatment.
2) Patients undergoing laparoscopic lateral sectionectomy of liver
(1) Performance status 0 or 1
(2) Patients who meet the following criteria and have bone marrow function that can appropriately evaluated safety
a) White blood cells >/= 3500 /mm2
b) Hemoglobin >/= 10.0 g/dl
c) Platelets >/= 100000 /mm2
(3) Patients who met the following criteria and have liver function that can appropriately evaluated safety.
a) Total serum bilirubin < 2.0mg/dl
b) AST < 100 IU/L
c) ALT < 100 IU/L
d) ICG stagnation rate at 15 minutes < 20 %
e) PT > 80 %
f) Ascites: None
g) Hepatic encephalopathy: None

Key exclusion criteria

2) Patients undergoing laparoscopic lateral sectionectomy of liver
(1) Patients with a history of upper abdominal surgery
(2) Patients with severe renal damage
(3) Patients with bleeding tendency
(4) Patients who are judged to be inappropriate for this study by the doctor or the attending physician

Target sample size

30


Research contact person

Name of lead principal investigator

1st name KOICHIRO
Middle name
Last name SAKATA

Organization

Japan Seafarers Relief Association Moji Ekisaikai Hospital

Division name

Surgery

Zip code

801-8550

Address

1-3-1 Kiyotaki Mojiku, Kitakyushu city, Fukuoka, Japan

TEL

+81-093-321-0984

Email

atak51ks331007@gmail.com


Public contact

Name of contact person

1st name KOICHIRO
Middle name
Last name SAKATA

Organization

Japan Seafarers Relief Association Moji Ekisaikai Hospital

Division name

Surgery

Zip code

801-8550

Address

1-3-1 Kiyotaki Mojiku, Kitakyushu city, Fukuoka, Japan

TEL

+81-093-321-0984

Homepage URL


Email

atak51ks331007@gmail.com


Sponsor or person

Institute

Japan Seafarers Relief Association Moji Ekisaikai Hospital

Institute

Department

Personal name



Funding Source

Organization

Kitakyushu Medical Association

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Seafarers Relief Association Moji Ekisaikai Hospital

Address

1-3-1 Kiyotaki Mojiku, Kitakyushu city, Fukuoka, Japan

Tel

+81-093-321-0984

Email

atak51ks331007@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北九州市立医療センター(福岡)、北九州市立八幡病院(福岡)、一般社団法人平成紫川会小倉記念病院(福岡)、岩本内科医院(福岡)、独立行政法人労働者健康安全機構九州労災病院(福岡)


Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 01 Month 14 Day

Date of IRB

2021 Year 02 Month 12 Day

Anticipated trial start date

2021 Year 02 Month 19 Day

Last follow-up date

2021 Year 03 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 02 Month 17 Day

Last modified on

2021 Year 02 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049483


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name